Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: a review of the current guidelines and literature.

Hospital practice (1995)

Volumn 39, Issue 4, 2011, Pages 32-40

  Lemesle, Gilles ^a   Paparoni, Francesco ^b   Delhaye, Cedric ^b   Bonello, Laurent ^b   Lablanche, Jean Marc ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT;

CORONARY ARTERY THROMBOSIS; DRUG ELUTING STENT; HUMAN; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTENOSIS; REVIEW; RISK FACTOR;

CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; HUMANS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84856144470     PISSN: 21548331     EISSN: None     Source Type: Journal    
DOI: 10.3810/hp.2011.10.920     Document Type: Review

References (0)